Gerald J. Gleich

Q: What Schools Are Affiliated With Gerald J. Gleich

Gerald J. Gleich is affiliated with the following schools: University of Utah, University of Liverpool, University of Bath, University of Chicago, Mayo Clinic College of Medicine and Science, University of Naples Federico II

Gerald J. Gleich's AcademicInfluence.com Rankings

Gerald J. Gleich

Philosophy

#2390

World Rank

#4102

Historical Rank

Logic

#555

World Rank

#1010

Historical Rank

philosophy Degrees

Gerald J. Gleich

Biology

#2726

World Rank

#4294

Historical Rank

Immunology

#97

World Rank

#103

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Gerald J. Gleich's Degrees

Doctorate Medicine University of Utah
PhD Immunology University of Utah

Why Is Gerald J. Gleich Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Gerald J. Gleich's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. (2002) (1114)
Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. (1988) (916)
Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense (2008) (820)
The eosinophilic leukocyte: structure and function. (1986) (802)
Mechanisms of eosinophil-associated inflammation. (2000) (778)
Establishment of an immature mast cell line from a patient with mast cell leukemia. (1988) (762)
The eosinophil and bronchial asthma: current understanding. (1990) (723)
The eosinophil and the pathophysiology of asthma. (1986) (606)
Cytotoxic properties of the eosinophil major basic protein. (1979) (580)
Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes. (2012) (567)
Treatment of patients with the hypereosinophilic syndrome with mepolizumab. (2008) (520)
Immunobiology of eosinophils. (1984) (518)
Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis (2017) (509)
Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. (2010) (496)
Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. (2009) (465)
Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro. (1989) (440)
Cytotoxic effects of the guinea pig eosinophil major basic protein on tracheal epithelium. (1980) (435)
Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate. (2002) (418)
Strategies of Anti‐Cytokine Monoclonal Antibody Development: Immunoassay of IL‐10 and IL‐5 in Clinical Samples (1992) (406)
IgA-induced eosinophil degranulation. (1989) (401)
Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis. (1985) (393)
The biology of the eosinophilic leukocyte. (1993) (363)
Elevated levels of the eosinophil granule major basic protein in the sputum of patients with bronchial asthma. (1981) (356)
Granulocyte/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils (1991) (355)
Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE. (2014) (350)
Damage to schistosomula of Schistosoma mansoni induced directly by eosinophil major basic protein. (1979) (348)
Regulatory effect of cytokines on eosinophil degranulation. (1990) (347)
Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report. (2006) (339)
Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan. (1990) (335)
Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates. (1991) (324)
The eosinophil as a mediator of damage to respiratory epithelium: a model for bronchial hyperreactivity. (1988) (322)
A clinical and pathologic study of chronic sinusitis: the role of the eosinophil. (1988) (321)
Activation of basophil and mast cell histamine release by eosinophil granule major basic protein (1983) (317)
Measurement of IgE in normal and allergic serum by radioimmunoassay. (1971) (312)
An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use. (1990) (311)
Treatment of hypereosinophilic syndrome with imatinib mesilate (2002) (308)
Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway. (1991) (296)
The role of eosinophils in the pathogenesis of asthma. (1994) (291)
DEPOSITS OF EOSINOPHIL GRANULE PROTEINS IN CARDIAC TISSUES OF PATIENTS WITH EOSINOPHILIC ENDOMYOCARDIAL DISEASE (1987) (287)
Refining the definition of hypereosinophilic syndrome. (2010) (287)
Leukocytes and mediators in bronchoalveolar lavage during allergen-induced late-phase asthmatic reactions. (1989) (284)
Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein. (1989) (274)
Glucocorticoids inhibit cytokine-mediated eosinophil survival. (1991) (273)
Chronic rhinosinusitis: an enhanced immune response to ubiquitous airborne fungi. (2004) (267)
Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease. (1986) (265)
Effect of immunotherapy on immunoglobulin E and immunoglobulin G antibodies to ragweed antigens: a six-year prospective study. (1982) (239)
Episodic angioedema associated with eosinophilia. (1984) (230)
Stimulation of basophil and rat mast cell histamine release by eosinophil granule-derived cationic proteins. (1984) (228)
Elemental Diet Induces Histologic Response in Adult Eosinophilic Esophagitis (2013) (223)
The late phase of the immunoglobulin E-mediated reaction: a link between anaphylaxis and common allergic disease? (1982) (218)
Comparative properties of the Charcot-Leyden crystal protein and the major basic protein from human eosinophils. (1976) (213)
Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein. (1986) (213)
Elevated serum levels of the eosinophil granule major basic protein in patients with eosinophilia. (1981) (209)
Human eosinophil major basic protein causes hyperreactivity of respiratory smooth muscle. Role of the epithelium. (1988) (206)
Penicillin allergy: clinical experience with a battery of skin-test reagents. (1982) (204)
Increased numbers of hypodense eosinophils in the blood of patients with bronchial asthma. (1985) (202)
IDENTIFICATION OF A MAJOR BASIC PROTEIN IN GUINEA PIG EOSINOPHIL GRANULES (1973) (201)
Purification of human eosinophil-derived neurotoxin. (1981) (200)
Activation of platelets by eosinophil granule proteins (1990) (195)
Heterogeneity of human peripheral blood eosinophil-type colonies: evidence for a common basophil-eosinophil progenitor. (1985) (190)
Molecular cloning of the human eosinophil peroxidase. Evidence for the existence of a peroxidase multigene family (1989) (190)
Measurement of the potency of allergy extracts by their inhibitory capacities in the radioallergosorbent test. (1974) (189)
Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin. (1983) (188)
IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction. (1993) (187)
Efficacy, dose reduction, and resistance to high-dose fluticasone in patients with eosinophilic esophagitis. (2014) (186)
Eosinophil granule proteins in peripheral blood granulocytes (1992) (183)
Eosinophil infiltration and degranulation in normal human tissue (1998) (183)
Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma. (2013) (179)
In vitro killing of microfilariae of Brugia pahangi and Brugia malayi by eosinophil granule proteins. (1990) (178)
Expression of Recombinant Human Pregnancy-associated Plasma Protein-A and Identification of the Proform of Eosinophil Major Basic Protein as Its Physiological Inhibitor* (2000) (177)
Constitutive production of IL-4 and IL-10 and stimulated production of IL-8 by normal peripheral blood eosinophils. (1996) (175)
Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis. (1992) (175)
Ovalbumin Sensitization Changes the Inflammatory Response to Subsequent Parainfluenza Infection (1999) (175)
Characterization of "peak E," a novel amino acid associated with eosinophilia-myalgia syndrome. (1990) (168)
Localization of human eosinophil granule major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin by immunoelectron microscopy. (1986) (165)
Cytokines directly induce degranulation and superoxide production from human eosinophils. (1996) (162)
Blood eosinophils and eosinophil-derived proteins in allergic asthma. (1989) (159)
Eosinophil cationic granule proteins impair thrombomodulin function. A potential mechanism for thromboembolism in hypereosinophilic heart disease. (1993) (159)
Human eosinophils produce neurotrophins and secrete nerve growth factor on immunologic stimuli. (2002) (158)
Localization of Eosinophil Granule Major Basic Protein in Chronic Urticaria (1983) (157)
Comparative toxicity of purified human eosinophil granule cationic proteins for schistosomula of Schistosoma mansoni. (1985) (156)
Eosinophil- and eosinophil granule-mediated pneumocyte injury. (1985) (149)
Release of granule proteins from eosinophils cultured with IL-5. (1992) (149)
Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromes. (2013) (144)
Anaphylactic transfusion reactions associated with anti-IgA antibody. (1969) (141)
PHYSIOCHEMICAL AND BIOLOGICAL PROPERTIES OF THE MAJOR BASIC PROTEIN FROM GUINEA PIG EOSINOPHIL GRANULES (1974) (141)
Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field (2012) (140)
The clinical spectrum of the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Clinical features in 20 patients and aspects of pathophysiology. (1990) (138)
Eosinophilic differentiation of the human promyelocytic leukemia cell line, HL-60 (1984) (133)
Conjunctival deposition of eosinophil granule major basic protein in vernal keratoconjunctivitis and contact lens-associated giant papillary conjunctivitis. (1989) (129)
The hypereosinophilic syndromes: current concepts and treatments (2009) (129)
Extensive Eosinophil Degranulation and Peroxidase-Mediated Oxidation of Airway Proteins Do Not Occur in a Mouse Ovalbumin-Challenge Model of Pulmonary Inflammation1 (2001) (127)
Eosinophils alter colonic epithelial barrier function: role for major basic protein. (2005) (125)
Acidic precursor revealed in human eosinophil granule major basic protein cDNA [published erratum appears in J Exp Med 1989 Sep 1;170(3):1057] (1988) (124)
Striking deposition of toxic eosinophil major basic protein in mucus: implications for chronic rhinosinusitis. (2005) (124)
Eosinophil cationic protein cDNA. Comparison with other toxic cationic proteins and ribonucleases. (1989) (123)
Formation of Charcot-Leyden crystals by human basophils (1982) (122)
Damage to Trichinella spiralis newborn larvae by eosinophil major basic protein. (1979) (122)
EGO, a novel, noncoding RNA gene, regulates eosinophil granule protein transcript expression. (2007) (122)
Eosinophil-Derived Cationic Proteins Activate the Synthesis of Remodeling Factors by Airway Epithelial Cells1 (2006) (121)
Allergen-specific IgG1 and IgG3 through Fc gamma RII induce eosinophil degranulation. (1995) (119)
Regulation of Ig-induced eosinophil degranulation by adenosine 3',5'-cyclic monophosphate. (1991) (116)
Deposition of eosinophil granule major basic protein in eosinophilic gastroenteritis and celiac disease. (1992) (116)
Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases (2016) (116)
Localization of the guinea pig eosinophil major basic protein to the core of the granule (1978) (115)
Repeated antigen inhalation results in a prolonged airway eosinophilia and airway hyperresponsiveness in primates. (1990) (112)
Localization of eosinophil‐derived neurotoxin and eosinophil cationic protein in neutrophilic leukocytes (1998) (111)
Chemokines active on eosinophils: potential roles in allergic inflammation (1996) (111)
A pathologic study of allergic bronchopulmonary aspergillosis. (1988) (111)
Biochemical and amino acid sequence analysis of human eosinophil granule major basic protein. (1988) (111)
Non-IgE-dependent activation of human lung- and cord blood-derived mast cells is induced by eosinophil major basic protein and modulated by the membrane form of stem cell factor. (2003) (110)
Eosinophil granule proteins activate human heart mast cells. (1996) (109)
IL-5 production by NK cells contributes to eosinophil infiltration in a mouse model of allergic inflammation. (1998) (108)
Localization of eosinophil granule major basic protein in human basophils (1983) (108)
Does IgE bind to and activate eosinophils from patients with allergy? (1999) (108)
Eosinophil-derived neurotoxin and human liver ribonuclease. Identity of structure and linkage of neurotoxicity to nuclease activity. (1992) (108)
The effect of purified human eosinophil major basic protein on mammalian ciliary activity. (2015) (108)
Dermal eosinophils in atopic dermatitis undergo cytolytic degeneration. (1997) (108)
Comparative toxicity of purified human eosinophil granule proteins for newborn larvae of Trichinella spiralis. (1987) (107)
Measurement of the absolute levels of IgE antibodies in patients with ragweed hay fever. (1977) (106)
Injurious effect of the eosinophil peroxide-hydrogen peroxide-halide system and major basic protein on human nasal epithelium in vitro. (1989) (106)
The eosinophilic injury to the mucosa of the airways in the pathogenesis of bronchial asthma. (1991) (105)
Seasonal changes in IgE antibodies and their relationship to IgG antibodies during immunotherapy for ragweed hay fever. (1973) (105)
Seasonal changes in serum and nassal IgE concentrations. (1973) (104)
Cytotoxicity of human eosinophil granule major basic protein to human nasal sinus mucosa in vitro. (1990) (104)
Cardiac localization of eosinophil-granule major basic protein in acute necrotizing myocarditis. (1990) (104)
What targeting eosinophils has taught us about their role in diseases. (2010) (103)
Interferon- Treatment of Six Patients with the Idiopathic Hypereosinophilic Syndrome (1994) (103)
Eosinophil major basic protein induces degranulation and IL-8 production by human eosinophils. (1995) (103)
Administration of interleukin-2 (IL-2) results in increased plasma concentrations of IL-5 and eosinophilia in patients with cancer. (1991) (102)
Heterogeneity of human eosinophils. (1989) (100)
Noncytotoxic activation of neutrophils by eosinophil granule major basic protein. Effect on superoxide anion generation and lysosomal enzyme release. (1990) (100)
Patchy eosinophil distributions in an esophagectomy specimen from a patient with eosinophilic esophagitis: Implications for endoscopic biopsy. (2012) (100)
Extracellular deposition of eosinophil and neutrophil granule proteins in the IgE-mediated cutaneous late phase reaction. (1990) (99)
Eosinophil granule major basic protein deposition in corneal ulcers associated with vernal keratoconjunctivitis. (1993) (99)
IgE levels in atopic dermatitis. (1973) (98)
Mepolizumab as a corticosteroid-sparing agent in lymphocytic variant hypereosinophilic syndrome. (2010) (98)
Deposition of eosinophil granule major basic protein onto microfilariae of Onchocerca volvulus in the skin of patients treated with diethylcarbamazine. (1984) (94)
The injurious effect of eosinophil peroxidase, hydrogen peroxide, and halides on pneumocytes in vitro. (1987) (94)
Assessment of eosinophil and neutrophil participation in atopic dermatitis: comparison with the IgE-mediated late-phase reaction. (1994) (94)
Novel targeted therapies for eosinophilic disorders. (2012) (93)
Charcot-Leyden crystal protein and eosinophil granule major basic protein in sputum of patients with respiratory diseases. (1984) (92)
A crucial role for beta 2 integrin in the activation of eosinophils stimulated by IgG. (1995) (92)
Structure and chromosome localization of the human eosinophil-derived neurotoxin and eosinophil cationic protein genes: evidence for intronless coding sequences in the ribonuclease gene superfamily. (1990) (92)
Deposition of eosinophil granule proteins precedes blister formation in bullous pemphigoid. Comparison with neutrophil and mast cell granule proteins. (1996) (92)
RANTES, Macrophage-Inhibitory Protein 1α, and the Eosinophil Product Major Basic Protein Are Released into Upper Respiratory Secretions during Virus-Induced Asthma Exacerbations in Children (1999) (92)
Australia antigen in chronic active liver disease with cirrhosis. (1969) (91)
Eosinophil granule major basic protein and Charcot-Leyden crystal protein in human tears. (1981) (91)
Ultrastructural study of eosinophils from patients with the hypereosinophilic syndrome: a morphological basis of hypodense eosinophils. (1988) (91)
Genetic transmission of serum IgE Levels. (1981) (91)
The cross-reactivity of IgE antibodies with pollen allergens. I. Analyses of various species of grass pollens. (1976) (89)
Effects of eosinophil granule proteins on human corneal epithelial cell viability and morphology. (1997) (89)
Immunoglobulin E antibodies to pollen allergens account for high percentages of total immunoglobulin E protein (1975) (88)
Eosinophilic myocarditis manifesting as myocardial infarction: early diagnosis and successful treatment. (1997) (87)
Acute interstitial nephritis: immunologic and clinical aspects. (1988) (86)
Treatment of asthma with nebulized lidocaine: a randomized, placebo-controlled study. (2004) (86)
Electron microscopy elucidates eosinophil degranulation patterns in patients with eosinophilic esophagitis. (2014) (86)
Synergism between eosinophil cationic protein and oxygen metabolites in killing of schistosomula of Schistosoma mansoni. (1987) (84)
Endogenous platelet-activating factor is critically involved in effector functions of eosinophils stimulated with IL-5 or IgG. (1999) (84)
Comparison of antifading agents used in immunofluorescence. (1989) (83)
Regulation of human eosinophil NADPH oxidase activity: A central role for PKCδ (2001) (83)
Ammonium chloride exposure inhibits cytokine-mediated eosinophil survival. (1994) (82)
Lidocaine and its analogues inhibit IL-5-mediated survival and activation of human eosinophils. (1998) (81)
Calcium ionophore A23187 calcium-dependent cytolytic degranulation in human eosinophils. (1985) (80)
Major basic protein and eosinophil-derived neurotoxin concentrations in nasal-lavage fluid after antigen challenge: effect of systemic corticosteroids and relationship to eosinophil influx. (1989) (80)
Eosinophil degranulation. An immunologic determinant in the pathogenesis of the Mazzotti reaction in human onchocerciasis. (1990) (79)
Effect of human eosinophil major basic protein on ion transport in dog tracheal epithelium. (1988) (79)
Eosinophilia-myalgia syndrome and tryptophan production: a cautionary tale. (1994) (79)
Induction of nasal late-phase reactions by insufflation of ragweed-pollen extract. (1984) (79)
Two highly homologous ribonuclease genes expressed in mouse eosinophils identify a larger subgroup of the mammalian ribonuclease superfamily. (1996) (78)
Human eosinophils induce histamine release from antigen-activated rat peritoneal mast cells: a possible role for mast cells in late-phase allergic reactions. (2001) (77)
Toxic effects produced or mediated by human eosinophil granule components on Trypanosoma cruzi. (1988) (77)
Acidic polyamino acids inhibit human eosinophil granule major basic protein toxicity. Evidence of a functional role for ProMBP. (1991) (77)
Eosinophils retain their granule major basic protein in a murine model of allergic pulmonary inflammation. (1998) (77)
Studies on Alternaria allergens. II. Measurement of the relative potency of commercial Alternaria extracts by the direct RAST and by RAST inhibition. (1976) (74)
Serum IgE in dermatitis and dermatosis: an analysis of 497 cases. (1977) (74)
BENIGN HYPERGAMMAGLOBULINEMIC PURPURA OF WALDENSTRÖM (1971) (74)
Increased eosinophil granule proteins in gut lavage fluid from patients with inflammatory bowel disease. (1997) (73)
Effect of steroids on immunoglobulin-induced eosinophil degranulation. (1991) (73)
Antigen-induced hyperreactivity to histamine: role of the vagus nerves and eosinophils. (1999) (73)
The molecular biology of eosinophil granule proteins. (1991) (73)
The neutrophil and chronic allergic inflammation. Immunochemical localization of neutrophil elastase. (1990) (72)
Identification of Angiotensinogen and Complement C3dg as Novel Proteins Binding the Proform of Eosinophil Major Basic Protein in Human Pregnancy Serum and Plasma (*) (1995) (72)
Maximal rise in IgE antibody following ragweed pollination season. (1975) (71)
A Novel and Highly Divergent Homolog of Human Eosinophil Granule Major Basic Protein* (1999) (70)
Studies on Alternaria allergens. I. Establishment of the radioallergosorbent test for measurement of Alternaria allergens. (1976) (70)
Measurement of histamine: a quality control study. (1980) (70)
Localization of a molecule immunochemically similar to eosinophil major basic protein in human placenta (1984) (69)
Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitis. (2019) (68)
Regulation and processing of a precursor form of eosinophil granule major basic protein (ProMBP) in differentiating eosinophils. (1998) (68)
The eosinophil as an effector cell of the immune response during hepatic allograft rejection (1994) (68)
Epithelial augmentation of trachealis contraction caused by major basic protein of eosinophils. (1989) (68)
Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis (1999) (68)
Increased eosinophil infiltration and degranulation in colonic tissue from patients with collagenous colitis (2001) (67)
Effects of eosinophils on mast cells: a new pathway for the perpetuation of allergic inflammation. (2002) (67)
An immunofluorescent method for specific staining of eosinophil granule major basic protein. (1981) (67)
The cross-reactivity of IgE antibodies with pollen allergens. II. Analyses of various species of ragweed and other fall weed pollens. (1976) (66)
Melittin: an allergen of honeybee venom. (1977) (66)
Endomyocardiopathy with eosinophilia. (1976) (65)
Epithelium-dependent contraction of airway smooth muscle caused by eosinophil MBP. (1990) (65)
Granule‐associated flavin adenine dinucleotide (FAD) is responsible for eosinophil autofluorescence (1992) (65)
Hypereosinophilic syndrome: case presentation and update. (2004) (63)
Sequence of human eosinophil-derived neurotoxin cDNA: identity of deduced amino acid sequence with human nonsecretory ribonucleases. (1989) (63)
Biological Activities of Ecalectin: A Novel Eosinophil-Activating Factor1 (2002) (62)
Eosinophil‐induced chronic active hepatitis in the idiopathic hypereosinophilic syndrome (1991) (62)
Familial eosinophilic cellulitis, dysmorphic habitus, and mental retardation. (1998) (62)
Eosinophil granule major basic protein inhibition of corneal epithelial wound healing. (1994) (61)
Efficacy and safety of mepolizumab in hypereosinophilic syndrome: A phase III, randomized, placebo-controlled trial (2020) (61)
elevated serum levels of interleukin-5 in patients with the syndrome of episodic angioedema and eosinophilia (1992) (61)
Localization of eosinophil granule major basic protein in chronic urticaria. (1983) (61)
Maternal floor infarction: relationship to X cells, major basic protein, and adverse perinatal outcome. (1992) (61)
Response of six patients with idiopathic hypereosinophilic syndrome to interferon alfa. (1994) (60)
3-(Phenylamino)alanine, a novel aniline-derived amino acid associated with the eosinophilia-myalgia syndrome: a link to the toxic oil syndrome? (1992) (60)
Eosinophil major basic protein: first identified natural heparanase-inhibiting protein. (2004) (59)
Evaluation of IgE tests in an allergy practice. (1971) (59)
The human eosinophil Charcot-Leyden crystal protein: biochemical characteristics and measurement by radioimmunoassay. (1980) (59)
Measurement of IgE antibodies by the radioallergosorbent test. I. Technical considerations in the performance of the test. (1975) (59)
Eosinophil granule proteins increase microvascular macromolecular transport in the hamster cheek pouch. (1994) (58)
Structural characterization of contaminants found in commercial preparations of melatonin: similarities to case-related compounds from L-tryptophan associated with eosinophilia-myalgia syndrome. (1998) (58)
Exploring Potential Noninvasive Biomarkers in Eosinophilic Esophagitis in Children (2011) (57)
Destruction of bloodstream forms of Trypanosoma cruzi by eosinophil granule major basic protein. (1981) (57)
Biochemical Evidence for Heme Linkage through Esters with Asp-93 and Glu-241 in Human Eosinophil Peroxidase (1999) (57)
Recurrent incapacitating mucosal ulcerations. A prodrome of the hypereosinophilic syndrome. (1982) (57)
Detection of allergy to nuts by the radioallergosorbent test. (1976) (57)
The eosinophilic leukocyte and the pathology of fatal bronchial asthma: evidence for pathologic heterogeneity. (1987) (57)
Immunological and biochemical studies in beekeepers and their family members. (1978) (56)
Elevated serum levels in human pregnancy of a molecule immunochemically similar to eosinophil granule major basic protein (1983) (56)
Measurement of IgD by a double antibody radioimmunoassay: demonstration of an apparent trimodal distribution of IgD levels in normal human sera. (1977) (56)
Report from the National Institute of Allergy and Infectious Diseases workshop on drug allergy. (2015) (55)
Bronchial asthma: lessons from murine models. (1997) (55)
Eosinophil-granule major basic protein, a C-type lectin, binds heparin. (2005) (54)
Preseasonal intranasal immunotherapy with nebulized short ragweed extract. (1981) (53)
Production of human immunoglobulin E antibody in vitro. (1979) (53)
Thrombotic microangiopathy associated with the hypereosinophilic syndrome. (2005) (53)
Chronic eosinophilic pneumonia. Evidence for eosinophil degranulation and release of major basic protein. (1986) (52)
Atopic dermatitis and IgE. Relationship between changes in IgE levels and severity of disease. (1976) (52)
Differences between IgA and IgE as secretory proteins. (1975) (52)
Failure to Transfer Bullous Pemphigoid with Serum from Patients (1971) (52)
Extracellular matrix proteins attenuate activation and degranulation of stimulated eosinophils. (1996) (52)
Interference in ragweed pollen and honeybee venom radioallergosorbent tests. (1980) (51)
Measurement of ragweed antigen E by double antibody radioimmunoassay. (1972) (51)
Low molecular weight IgM in human sera. (1969) (51)
Workshop report from the National Institutes of Health Taskforce on the Research Needs of Eosinophil-Associated Diseases (TREAD). (2012) (50)
Elevated serum levels of interleukin-5 in patients with the syndrome of episodic angioedema and eosinophilia. (1992) (50)
The identification and cloning of a murine major basic protein gene expressed in eosinophils. (1995) (50)
Dermatologic manifestations of the hypereosinophilic syndromes. (2007) (50)
Stimulation of neutrophil interleukin-8 production by eosinophil granule major basic protein. (1999) (49)
The induction of eosinophil peroxidase release: improved methods of measurement and stimulation. (2004) (49)
Effects of human eosinophil granule-derived cationic proteins on C-fiber afferents in the rat lung. (2001) (49)
Crystal Structure of the Eosinophil Major Basic Protein at 1.8 Å (2001) (48)
Analysis of pregnancy-associated major basic protein levels throughout gestation. (1993) (48)
Role of pertussis toxin-sensitive G proteins in stimulus-dependent human eosinophil degranulation. (1991) (48)
Steroid-responsive eosinophilic myocarditis: diagnosis by endomyocardial biopsy. (1984) (48)
Eosinophils and human disease. (1989) (47)
Sulfonylureas inhibit cytokine-induced eosinophil survival and activation. (1998) (46)
The mini-RAST: Comparison with other varieties of the radioallergosorbent test for the measurement of immunoglobulin E antibodies. (1980) (46)
The spectrum of eosinophilic myositis (1993) (46)
Reactivity of ragweed allergens with IgE antibodies. Analyses by leukocyte histamine release and the radioallergosorbent test and determination of cross-reactivity. (1978) (46)
Allergy to tobacco: an occupational hazard. (1980) (45)
Interferon-alpha treatment of six patients with the idiopathic hypereosinophilic syndrome. (1994) (45)
Roles of CD9 molecules in survival and activation of human eosinophils. (1997) (45)
Eosinophil viability during immunoglobulin‐induced degranulation (1996) (45)
Clinical reviews in allergy and immunology (2012) (44)
Mechanism of topical glucocorticoid treatment of hay fever: IL-5 and eosinophil activation during natural allergen exposure are suppressed, but IL-4, IL-6, and IgE antibody production are unaffected. (2000) (44)
Eosinophils in Allergy and Inflammation (1994) (44)
Churg-Strauss syndrome: localization of eosinophil major basic protein in damaged tissues. (2000) (44)
Interactions of eosinophil granule proteins with skin: limits of detection, persistence, and vasopermeabilization. (2003) (44)
Localization of eosinophil major basic protein onto eggs of Schistosoma mansoni in human pathologic tissue. (1988) (43)
Allergen-controlled study of intranasal immunotherapy for ragweed hay fever. (1983) (43)
Pharmacological control of human basophil histamine release stimulated by eosinophil granule major basic protein. (1989) (43)
Allergic fungal sinusitis: an immunohistologic analysis. (2000) (42)
Differing patterns of wheal and flare skin reactivity in patients allergic to the penicillins. (1971) (42)
Eosinophil-associated inflammation and elaboration of eosinophil-derived proteins in 2 children with raccoon roundworm (Baylisascaris procyonis) encephalitis. (2001) (42)
The hypereosinophilic syndromes: still more heterogeneity. (2005) (42)
The eosinophil and cutaneous edema. (1986) (41)
Sensitization of isolated rat vagal pulmonary sensory neurons by eosinophil-derived cationic proteins. (2008) (41)
Aging and serum immunoglobulin E levels, immediate skin tests, RAST. (1981) (40)
The prevalence of alpha 1-antitrypsin deficiency in selected groups of patients with chronic obstructive lung disease. (1969) (40)
Regulation of eosinophil membrane depolarization during NADPH oxidase activation (2003) (40)
Identification of basophils by a mAb directed against pro-major basic protein 1. (2006) (40)
Eosinophil granule major basic protein in acute renal allograft rejection. (1989) (39)
Interaction of eosinophil granule major basic protein with synthetic lipid bilayers: A mechanism for toxicity (1992) (39)
Eosinophil activation and function in health and disease. (1992) (39)
Immunoglobulin E (IgE) levels in serum and synovial fluid in rheumatoid arthritis. (1974) (39)
Diverse effects of eosinophil cationic granule proteins on IMR-32 nerve cell signaling and survival. (2005) (38)
IL-3, IL-5, and granulocyte-macrophage colony-stimulating factor potentiate basophil mediator release stimulated by eosinophil granule major basic protein. (1995) (38)
Lack of suppression of IgE production by recombinant interferon gamma: a controlled trial in patients with allergic rhinitis. (1990) (38)
Increases of plasma eosinophil major basic protein levels late in pregnancy predict onset of labor. (1987) (38)
Current understanding of eosinophil function. (1988) (37)
The eosinophil: new aspects of structure and function. (1977) (37)
Eosinophil infiltration and degranulation inHelicobacter pylori-associated chronic gastritis (1991) (37)
Food allergy manifested by eosinophilia, elevated immunoglobulin E level, and protein-losing enteropathy: the syndrome of allergic gastroenteropathy. (1982) (37)
Activated Eosinophils in Association with Enteric Nerves in Inflammatory Bowel Disease (2013) (36)
Antigen Combining Activity Associated with Immunoglobulin D (1969) (36)
Eosinophils and bronchial inflammation. (1985) (36)
Comparison of the protein-binding capacities of cyanogen bromide-activated polysaccharides. (1972) (36)
Sequestration of eosinophil major basic protein in human mast cells. (1990) (36)
Eosinophilia and gastrointestinal symptoms after ingestion of shiitake mushrooms. (1998) (36)
Cytotoxic Properties of Eosinophil Granule Major Basic Protein for Tumor Cells (1999) (36)
Effect of eosinophil adhesion on intracellular signaling in cholinergic nerve cells. (2004) (36)
Penicillin skin tests as predictive and diagnostic aids in penicillin allergy. (1970) (36)
Eosinophil Major Basic Protein Stimulates Neutrophil Superoxide Production by a Class IA Phosphoinositide 3-Kinase and Protein Kinase C-ζ-Dependent Pathway1 (2003) (36)
Analysis of signaling events associated with activation of neutrophil superoxide anion production by eosinophil granule major basic protein. (1995) (35)
Eosinophilia and elevated serum levels of eosinophil major basic protein and Charcot-Leyden crystal protein (lysophospholipase) after treatment of patients with Bancroft's filariasis. (1981) (35)
Comparison of procedures for measurement of IgE protein in serum and secretions. (1977) (35)
Tissue eosinophilia and eosinophil degranulation in Riedel's invasive fibrous thyroiditis. (1996) (35)
Identification and validation of shrimp-tropomyosin specific CD4 T cell epitopes. (2013) (34)
The changing role of eosinophils in long-term hyperreactivity following a single ozone exposure. (2005) (34)
Evidence of eosinophil granule major basic protein in human placenta (1989) (34)
Preseasonal IgE ragweed antibody level as a predictor of response to therapy of ragweed hay fever with intranasal cromolyn sodium solution. (1977) (34)
Mechanisms of eosinophil major basic protein-induced hyperexcitability of vagal pulmonary chemosensitive neurons. (2009) (34)
Immunofluorescent localization of eosinophil granule major basic protein in fatal human cases of Baylisascaris procyonis infection. (1989) (34)
Effects of eosinophils on nerve cell morphology and development: the role of reactive oxygen species and p38 MAP kinase. (2003) (33)
Major Basic Protein Homolog (MBP2): A Specific Human Eosinophil Marker1 (2006) (33)
Biotransformation of 3-(phenylamino)-1,2-propanediol to 3-(phenylamino)alanine: a chemical link between toxic oil syndrome and eosinophilia-myalgia syndrome. (1995) (33)
Extracellular deposition of eosinophil granule major basic protein in pressure urticaria. (1987) (33)
On-line HPLC-tandem mass spectrometry analysis of contaminants of L-tryptophan associated with the onset of the eosinophilia-myalgia syndrome. (1997) (33)
Differences between basophils and mast cells: failure to detect Charcot-Leyden crystal protein (lysophospholipase) and eosinophil granule major basic protein in human mast cells. (1986) (33)
Ragweed-specific IgA in nasal lavage fluid of ragweed-sensitive allergic rhinitis patients: increase during the pollen season. (1991) (33)
Selective stimulation and purification of eosinophils and neutrophils from guinea pig peritoneal fluids. (1973) (32)
Eosinophil Infiltration and Degranulation in Normal Human Tissues: Evidence for Eosinophil Degranulation in Normal Gastrointestinal Tract (2001) (32)
Comparison of binding of IgE and IgG antibodies to honeybee venom phospholipase-A. (1978) (31)
The proform of eosinophil major basic protein: a new maternal serum marker for Down syndrome (1999) (31)
Revisiting the NIH Taskforce on the Research needs of Eosinophil‐Associated Diseases (RE‐TREAD) (2018) (31)
Facial edema and eosinophilia. Evidence for eosinophil degranulation. (1985) (31)
Human eosinophil-derived neurotoxin and eosinophil protein X are likely the same protein. (1989) (30)
Localization of IgE to lung germinal lymphoid follicles in a patient with allergic bronchopulmonary aspergillosis. (1992) (30)
Localization of Eosinophil–Derived Neurotoxin and Eosinophil Cationic Protein in Neutrophilic Leukocytes (1999) (29)
Elevated levels of eosinophil major basic protein in the sera of patients with systemic sclerosis. (1995) (29)
Extracellular deposition of eosinophil granule major basic protein in lymph nodes of patients with Hodgkin's disease. (1986) (29)
On-line HPLC-tandem mass spectrometry structural characterization of case-associated contaminants of L-tryptophan implicated with the onset of eosinophilia myalgia syndrome. (1998) (29)
Eosinophil granule proteins are selective activators of human heart mast cells. (1997) (29)
Evidence for pathogenic involvementof eosinophils and neutrophilsin Churg-Strauss syndrome. (2002) (29)
ICON: Eosinophil Disorders (2012) (29)
Cloning and sequence analysis of the human gene encoding eosinophil major basic protein. (1990) (29)
Proteolytic degradation of IgD and its relation to molecular conformation. (1972) (28)
Tissue eosinophilia and eosinophil degranulation in orbital pseudotumor. (1991) (28)
Chronic acral dermatitis: association with extreme elevations of IgE. (1973) (27)
Antigen-Specific IgG and IgA, but Not IgE, Activate the Effector Functions of Eosinophils in the Presence of Antigen (2010) (27)
The effect of omalizumab dosing and frequency in chronic idiopathic urticaria: Retrospective chart review. (2016) (27)
Human eosinophil granule major basic protein and its novel homolog (1998) (27)
Atropine-enhanced, antigen challenge-induced airway hyperreactivity in guinea pigs is mediated by eosinophils and nerve growth factor. (2009) (27)
Measurement of IgG blocking antibodies by interference in the radioallergosorbent test. (1981) (27)
Shrimp allergy: Gastrointestinal symptoms commonly occur in the absence of IgE sensitization. (2016) (27)
Release of eosinophil granule proteins during IgE-mediated allergic skin reactions. (1991) (27)
Variability of IgE protein measurement in cell-culture supernatants: results from a multicenter collaborative study. (1986) (27)
The effect of antiserum to eosinophils and susceptibility and acquired immunity of the guinea-pig to trichostronglyus colubriformis. (1979) (27)
Esophageal stricture following chloral hydrate poisoning. (1967) (27)
Localization of eosinophil granule major basic protein in paracoccidioidomycosis lesions. (1998) (26)
Allergy to human seminal fluid. (1975) (26)
Isolation and characterization of Russian thistle (Salsola pestifer) pollen allergens. (1981) (26)
Evidence for secretion of human eosinophil granule major basic protein and Charcot-Leyden crystal protein during eosinophil maturation. (1984) (26)
Effects of glucocorticoids on eosinophil colony growth. (1986) (25)
Eosinophil granule proteins and bronchial asthma (1996) (25)
Immune deficiency diseases. (1973) (25)
Analysis of the potency of extracts of June grass pollen by their inhibitory capacities in the radioallergosorbent test. (1976) (25)
Measurement of IgE antibodies by the radioallergosorbent test. II. Analyses of quantitative relationships in the test. (1975) (24)
A Pilot Study of the Treatment of Eosinophilic Esophagitis With Omalizumab (2011) (24)
Penaeus monodon tropomyosin induces CD4 T-cell proliferation in shrimp-allergic patients. (2012) (24)
Repeated coronary artery spasm in a young woman with the eosinophilia-myalgia syndrome. (1992) (24)
Raised serum immunoglobulin E in Wegener's granulomatosis. (1976) (24)
Reactivity of monoclonal antibodies EG1 and EG2 with eosinophils and their granule proteins (1999) (24)
Immunoglobulin E in Chronic Middle Ear Effusions (1978) (23)
Placental site trophoblastic tumor: human placental lactogen and pregnancy-associated major basic protein as immunohistologic markers. (1998) (23)
A novel human homolog of eosinophil major basic protein (2001) (22)
Use of cholestyramine to control diarrhea associated with acquired hypogammaglobulinemia. (1971) (22)
Antiserum to the major basic protein of guinea pig eosinophil granules. (1976) (22)
Eosinophil recruitment to nasal nerves after allergen challenge in allergic rhinitis. (2013) (22)
Immunoglobulin classes of antibodies produced in the primary and secondary responses in man. (1969) (22)
Eosinophil granule protein localization in eosinophilic endomyocardial disease. (2011) (22)
Inheritance of low serum immunoglobulin D. (1978) (22)
The spectrum of eosinophilic myositis. Clinical and immunopathogenic studies of three patients, and review of the literature. (1993) (22)
Measurement of guinea pig eosinophil major basic protein by radioimmunoassay. (1979) (21)
Comparison of certain properties of naturally occurring low molecular weight Gamma M and the Gamma M monomer derived by reduction and alkylation of 19S Gamma M. (1968) (21)
Eosinophil Ribonucleases and Their Cutaneous Lesion-Forming Activity1 (2009) (21)
Expression of eosinophil-granule major basic protein messenger ribonucleic acid in placental X cells. (1994) (21)
THE EOSINOPHIL AND BRONCHIAL ASTHMA : EVIDENCE FOR A CRITICAL ROLE OF EOSINOPHILS IN PATHOPHYSIOLOGY (1999) (21)
IgG subclasses in monoclonal gammopathy of undetermined significance. (1982) (21)
Eosinophils and IgE receptors: a continuing controversy. (1997) (21)
Myiasis due to Hypoderma lineatum infection mimicking the hypereosinophilic syndrome. (2000) (21)
Eosinophilia and fluid retention in systemic administration of interleukin-2. (1986) (21)
Microbiologic analyses of nasal polyp tissue. (1986) (21)
Localization of disulfide bridges and free sulfhydryl groups in human eosinophil granule major basic protein (1994) (21)
Measurement of penicilloyl antibodies by radioimmunoprecipitation. (1969) (21)
Bronchial hyperreactivity and eosinophil granule proteins. (1993) (20)
The pathology of asthma: with emphasis on the role of the eosinophil. (1986) (20)
Effect of corticosteroids on seasonal increases in IgE antibody. (1973) (20)
Eosinophil-associated inflammation in bronchial asthma: a connection to the nervous system. (1995) (20)
Serum immunoglobulin levels in cholestasis. (1969) (20)
The effect of cromolyn sodium powder as a treatment for ragweed pollinosis. (1975) (20)
Structural characterization of a case-implicated contaminant, "Peak X," in commercial preparations of 5-hydroxytryptophan. (2003) (19)
Mechanisms of smooth muscle contraction elicited by cationic proteins in guinea pig trachealis. (1996) (19)
Eosinophils and IgE Receptors: A Continuing Controversy (1997) (19)
Alpha 1-antitrypsin in serum and synovial fluid in rheumatoid arthritis. (1974) (19)
The heat stability of short ragweed pollen extract and the importance of individual allergens in skin reactivity. (1980) (19)
The expanding clinical spectrum of multisystem disease associated with eosinophilia. (1997) (19)
Chemotaxis of eosinophils and neutrophils by aggregated immunoglobulins. (1971) (19)
Comparison of Sensitivities of Immunodiffusion Methods∗ (1968) (18)
Chapter 4 Eosinophils, basophils, and mast cells (1989) (18)
Membrane preconcentration‐capillary electrophoresis‐mass spectrometry (mPC‐CE‐MS) analysis of 3‐phenylamino‐1,2‐propanediol (PAP) metabolites (1996) (18)
Inhibition of the activation of hageman factor (factor XII) by eosinophils and eosinophilic constituents (1993) (18)
Structural characterization of contaminants in commercial preparations of melatonin by on-line HPLC-electrospray ionization-tandem mass spectrometry. (1999) (18)
MHC-linked genetic control of the immune response to parasites: Trichinella spiralis in the mouse. (1980) (18)
Eosinophils Activate Mast Cells to Release Histamine (1999) (18)
Utility of an Elemental Diet in Adult Eosinophilic Esophagitis (2011) (18)
The effect of cationic charge on release of eosinophil mediators. (2008) (17)
Problems with over-the-counter 5-hydroxy-L-tryptophan (1998) (17)
Eosinophil Cationic Granule Proteins Impair Thrombomodulin Function (1993) (17)
Studies on IgA and IgG monoclonal proteins derived from a single patient. I. Evidence for shared individually specific antigenic determinants. (1974) (17)
Hyperviscosity syndrome associated with immunoglobulin A myeloma. (1972) (17)
Tyrosine phosphorylation and inositol phosphate production: are early events in human eosinophil activation stimulated by immobilized secretory IgA and IgG? (1994) (17)
The eosinophil leukocyte: maturation and function. (1983) (17)
The effect of ablation of eosinophils on immediate-type hypersensitivity reactions. (1979) (17)
Eosinophil and neutrophil degranulation in ophthalmic lesions of Wegener's granulomatosis. (1991) (17)
Differential extraction of eosinophil granule proteins. (2005) (17)
Eosinophilia-myalgia syndrome case-associated contaminants in commercially available 5-hydroxytryptophan. (1999) (16)
Eosinophil granule major basic protein regulates generation of classical and alternative-amplification pathway C3 convertases in vitro. (1988) (16)
Eosinophilic endomyocardial disease presenting as cyanosis, platypnea, and orthodeoxia. (1992) (16)
Inhibition of antibody-dependent eosinophil-mediated cytotoxicity by heparin. (1982) (16)
Demonstration of immunoreactive eosinophil granule major basic protein in the plasma and placentae of non-human primates. (1987) (16)
Eosinophil peroxidase signals via epidermal growth factor-2 to induce cell proliferation. (2011) (16)
Reproducibility of a Single Blood Eosinophil Measurement as a Biomarker in Severe Eosinophilic Asthma. (2015) (16)
Extracellular Eosinophil Granule Protein Deposition in Ringed Esophagus with Sparse Eosinophils (2015) (16)
Topical ocular administration of cromolyn sodium for treatment in seasonal ragweed conjunctivitis. (1979) (16)
Serum immunoglobulin levels in blood donors implicated in transmission of hepatitis. (1968) (15)
⁹⁹mTechnetium-labeled heparin: a new approach to detection of eosinophilic esophagitis-associated inflammation. (2013) (15)
Immunoglobulin concentrations in serum and nasal secretions in chronic obstructive pulmonary disease. A matched-pair study. (1979) (15)
Episodic angioedema associated with eosinophilia. (1984) (15)
Eosinophils, basophils, and mast cells. (1989) (15)
Historical overview and perspective on the role of the eosinophil in health and disease (2012) (15)
Contaminants in commercial preparations of melatonin. (1997) (15)
Eosinophil differentiation of human umbilical cord mononuclear cells and prolonged survival of mature eosinophils by murine EL-4 thymoma cell conditioned medium. (1991) (15)
Hodgkin's disease and thymic alymphoplasia in a 5-month-old infant. (1970) (15)
Major basic protein as a predictor of preterm labor: a preliminary report. (1987) (15)
Treatment of FIP1L1/PDGFRA-negative hypereosinophilic syndrome with alemtuzumab, an anti-CD52 antibody. (2009) (15)
Seasonal variation of in vitro lymphocyte proliferative response to ragweed antigen E. (1985) (15)
Immunochemical studies on some immune systems involving ß(1,4) linked glucose (1965) (14)
Eosinophils 1992. (1992) (14)
The eosinophilia-myalgia syndrome revisited. (1996) (14)
Release of kinins from site of wheal-and-flare allergic skin reactions. (1970) (14)
Angioneurotic edema and deficiency of C'1 esterase inhibitor in a 61-year-old woman. (1969) (14)
Inhibition of Eosinophilotaxis by Chloroquine and Corticosteroids 1 (1978) (14)
Eosinophil granule cationic proteins regulate complement. I. Activity on the alternative pathway. (1992) (14)
Sulochrin inhibits eosinophil degranulation. (1997) (14)
Systemic vasculitis associated with eosinophilia and marked degranulation of tissue eosinophils. (1988) (13)
The impact of the discovery of IgE on the practice of allergy. (1975) (13)
Ligation of IgE receptors causes an anaphylactic response and neutrophil infiltration but does not induce eosinophilic inflammation in mice. (2000) (13)
Eosinophil granule cationic proteins regulate the classical pathway of complement. (1995) (13)
Bile acids induce eosinophil degranulation by two different mechanisms (2001) (13)
Association of immunoreactive eosinophil major basic protein with placental septa and cysts. (1991) (13)
The radioallergosorbent test: a method to measure IgE antibodies, IgG blocking antibodies, and the potency of allergy extracts. (1981) (13)
Eosinophil major basic protein increases membrane permeability in mammalian urinary bladder epithelium. (1998) (13)
Ragweed hay fever: treatment by local passive administration of IgG antibody (1975) (12)
Peptide-based analysis of amino acid sequences important to the biological activity of eosinophil granule major basic protein. (2001) (12)
Measurement of Inflammation in Eosinophilic Esophagitis Using an Eosinophil Peroxidase Assay (2016) (12)
The eosinophil: structure and biochemical composition. (1977) (12)
Eosinophil-Associated Ribonucleases (1997) (12)
Two eosinophil granule proteins, eosinophil peroxidase and major basic protein, inhibit mucin release from hamster tracheal surface epithelial cells in primary culture (1999) (12)
Can Eosinophil Derived Neurotoxin (EDN) Act As a Surrogate Marker of Disease Activity in Children with Allergic Eosinophilic Esophagitis (AEE) (2004) (12)
The Eosinophil in Cardiac Disease (2003) (12)
Eosinophil granule major basic protein 1 deposition in eosinophilic esophagitis correlates with symptoms independent of eosinophil counts. (2019) (12)
JAK2ex13InDel drives oncogenic transformation and is associated with chronic eosinophilic leukemia and polycythemia vera. (2019) (12)
Polyarginine and eosinophil-derived major basic protein increase microvascular permeability independently of histamine or nitric oxide release. (1995) (12)
Recovery of eosinophils from the peritoneal cavity of the guinea pig. (1981) (12)
Some molecular characteristics of human urinary erytopoietin determined by gel filtration and density-gradient ultracentrifugation. (1970) (12)
Immunotherapy with short ragweed fraction A:D-glutamic acid:D-lysine polymer in ragweed hay fever. (1981) (11)
Mechanism of Sphingosine 1-Phosphate- and Lysophosphatidic Acid-Induced Up-Regulation of Adhesion Molecules and Eosinophil Chemoattractant in Nerve Cells (2011) (11)
Reactivity of rabbit antiserum to guinea pig eosinophils. (1975) (11)
Refractory periorbital edema in a 29-year-old man. (1992) (11)
Rapid HPLC screening method for contaminants found in implicated L-tryptophan associated with eosinophilia myalgia syndrome and adulterated rapeseed oil associated with toxic oil syndrome. (1998) (11)
Steroid-Sparing Effects of Anti-IL-5 Monoclonal Antibody (Mepolizumab) Therapy in Patients with HES: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. (2006) (11)
Comparison of ultrasensitive methods for the measurement of IgE. (1983) (10)
Localization and cellular distribution of pregnancy-associated plasma protein-a and major basic protein in human ovary and corpora lutea throughout the menstrual cycle. (2003) (10)
Pregnancy-associated major basic protein: deposition of protein and expression of mRNA at the maternal-fetal junction in early and late gestation. (1994) (10)
Immunochemical quantitation of an airborne proteolytic enzyme, Esperase, in a consumer products factory. (1986) (10)
Swiss-type agammaglobulinemia associated with an abnormality of the inflmmatory response (1966) (10)
The effect of fluticasone propionate aqueous nasal spray on eosinophils and cytokines in nasal secretions of patients with ragweed allergic rhinitis. (1997) (10)
Anaphylaxis: implications of monoclonal antibody use in oncology. (2009) (10)
Donor sensitivity to basophil activation by eosinophil granule major basic protein. (1985) (10)
Immunochemical and physiocochemical properties of tobacco extracts. (1979) (10)
An immunologic test for chronic rhinosinusitis based on free intranasal eosinophilic major basic protein (2015) (10)
Interactions between respiratory epithelium and eosinophil granule proteins in asthma : the eosinophil hypothesis (1991) (10)
1,1' ‐Ethylidenebis‐ [tryptophan] induces pathologic alterations in muscle similar to those observed in the eosinophilia‐myalgia syndrome (1994) (9)
[10] Comparative evaluation of quantitative PCR methods (1995) (9)
Discordant and anomalous results among cytotoxicity assays: the confounding properties of eosinophil granule major basic protein on cell viability assays. (1999) (9)
Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes (2022) (9)
Changes in the antigenic composition of the short ragweed plant during maturation. (1975) (9)
Detection of antibodies to proteases used in laundry detergents by the radioallergosorbent test. (1986) (9)
Elevations in granulocyte-macrophage colony-stimulating factor and interleukin-5 levels precede posttreatment eosinophilia in onchocerciasis. (1996) (9)
Some structural features of the antigenic groupings involved in the cross reaction of oat glucan with type 8 horse antipneumococcal serum. (1965) (9)
The eosinophil granule major basic protein: biological activities and relationship to bronchial asthma. (1983) (9)
Genes within the major histocompatibility complex influence susceptibility toTrichinella spiralis in the mouse (1979) (9)
Effect of Interleukin–3, Interleukin 5 and Hyaluronic Acid on Cultured Eosinophils Derived from Human Umbilical Cord Blood Mononuclear Cells (1999) (9)
Presence of peak X and related compounds: the reported contaminant in case related 5-hydroxy-L-tryptophan associated with eosinophilia-myalgia syndrome. (1999) (9)
Isolation and Partial Characterization of a Major Basic Protein from Rat Eosinophil Granules 1 (1976) (8)
The eosinophilia-myalgia syndrome: lessons from Germany. (1994) (8)
Treatment of the eosinophilia–myalgia syndrome (1990) (8)
Sulochrin inhibits eosinophil activation and chemotaxis (1998) (8)
Spermagglutinating activity and female infertility. A study of serum and genital tract secretions. (1973) (8)
LACK OF ASSOCIATION OF THE IMMUNE RESPONSE TO RAGWEED ANTIGEN E, Ra 3 AND Ra5 WITH THE HLA SYSTEM (1981) (8)
Eosinophil peroxidase activates cells by HER2 receptor engagement and β1-integrin clustering with downstream MAPK cell signaling (2016) (8)
Safety and efficacy of mepolizumab in hypereosinophilic syndrome: an open-label extension study. (2021) (8)
Pulmonary Eosinophilic Granulomatosis with Polyangiitis has IgG4 Plasma Cells and Immunoregulatory Features. (2020) (8)
Structure and activity of ragweed antigen E. II. Allergenic crossreactivity of the subunits. (1979) (8)
Tryptophan and eosinophilia-myalgia syndrome (1990) (8)
Cytotoxicity of eosinophil granule proteins for tumor cells (1988) (8)
Human Eosinophil Major Basic Protein 2: Location of Disulfide Bonds and Free Sulfhydryl Groups (2007) (7)
Pregnancy-associated major basic protein in amniotic fluid. (1992) (7)
Eosinophil granule major basic protein in contact lenses of patients with giant papillary conjunctivitis. (1990) (7)
Airway hypersensitivity induced by eosinophil granule-derived cationic proteins. (2019) (7)
Increases in cytosolic Ca2+ accompany basophil activation by eosinophil granule major basic protein. (1997) (7)
Development of eosinophilic endomyocardial disease in a patient with episodic angioedema and eosinophilia. (2016) (7)
Separation of active subunits of ragweed antigen E. (1978) (7)
Food‐specific antibodies in oesophageal secretions: association with trigger foods in eosinophilic oesophagitis (2020) (7)
Eosinophil-active cytokine from mononuclear cells cultured with L-tryptophan products: an unexpected consequence of endotoxin contamination. (1995) (6)
Eosinophils and neutrophils modify arachidonic acid-induced relaxation of guinea-pig trachea. (1996) (6)
Mepolizumab reduces hypereosinophilic syndrome flares irrespective of blood eosinophil count and IL-5. (2022) (6)
Pharyngeal mucosa brushing does not correlate with disease activity in patients with eosinophilic esophagitis. (2017) (6)
285 Monoclonal antibody to ALT-I and its use in affinity chromatography (1983) (6)
The IgE-Mediated Cutaneous Late-Phase Reaction (2004) (6)
High synovial immunoglobulin E levels in eosinophilic synovitis. (1992) (6)
173 Eosinophils, non-specific bronchial responsiveness, and allergen-induced late-phase asthmatic reactions (1985) (6)
Differences in the reactivity of short and giant ragweed with immunoglobulin E antibodies. (1980) (6)
Human eosinophil major basic protein augments bronchoconstriction induced by intravenous agonists in guinea pigs (2005) (6)
Allergen-specific IgG1 and IgG3 through FcRIl Induce Eosinophil Degranulation (2004) (6)
Serum IgD in subjects with and without chronic obstructive pulmonary disease: a previous finding restudied. (1982) (6)
Diagnosis of syndromes associated with hyperglobulinemia. (1970) (6)
Procurement and Purification of Eosinophils (1983) (6)
CONCISE COMMUNICATIONS RANTES, Macrophage-Inhibitory Protein 1a, and the Eosinophil Product Major Basic Protein Are Released into Upper Respiratory Secretions during Virus-Induced Asthma Exacerbations in Children (1999) (5)
96 Charcot-Leyden crystal protein and eosinophil granule major basic protein in sputum of patients with respiratory diseases (1983) (5)
Reactivity of polymer (19S) and monomer (7S) forms of gamma-M with anti-gamma M serum. (1969) (5)
A modular on-line three-dimensional liquid chromatography-tandem mass spectrometry approach to characterization of organelle proteomes. (2003) (5)
Cough responses to inhaled irritants are enhanced by eosinophil major basic protein in awake mice. (2019) (5)
Eosinophil peroxidase increases membrane permeability in mammalian urinary bladder epithelium. (1999) (5)
The effect of immune milk as a treatment for ragweed pollinosis. (1975) (5)
660 Eosinophil major basic protein (MBP) upregulates intercellular adhesion molecule-1 (ICAM-1) expression on human nasal epithelial cells (HNE) (1991) (5)
Comparative structure, proximal promoter elements, and chromosome location of the human eosinophil major basic protein genes. (2001) (5)
Absence of activity of first component of complement in man: association with thymic alymphoplasia and defective inflammatory response. (1967) (4)
Peak AAA fatty acid homolog contaminants present in the dietary supplement l-Tryptophan associated with the onset of eosinophilia-myalgia syndrome. (2018) (4)
Comparative Properties oftheCharcot-Leyden Crystal Protein andtheMajor Basic Protein fromHumanEosinophils (1976) (4)
Induction of prolonged inflammation in nasal mucosa by insufflation of ragweed pollen extract (1979) (4)
198 Stimulation of basophil and mast cell histamine release by human eosinophil granule major basic protein (1983) (4)
Chronic active liver disease with common variable hypogammaglobulinemia. (1979) (4)
Major basic protein as a marker of malignant potential in trophoblastic neoplasia. (1996) (4)
Measurement of the potency of pollen extract by radioimmunoprecipitation. (1979) (4)
Structure determination of disease associated peak AAA from l-Tryptophan implicated in the eosinophilia-myalgia syndrome. (2018) (4)
Structural characterization of case-associated contaminants peak C and FF in L-tryptophan implicated in eosinophilia-myalgia syndrome. (1999) (4)
46 Low density eosinophils in bronchial asthma (1985) (4)
Antigenic properties of polymeric and monomeric hemocyanin from Limulus polyphemus. (1970) (4)
Phosphate Binders in CKD: Bad News or Good News? (2012) (4)
Hypereosinophilia in an islet transplant recipient. (2005) (4)
Macromolecular contaminants in penicillin and cephalosporin antibiotics. (1971) (3)
Renal role in Goodpasture's syndrome. (1969) (3)
Over-the-counter melatonin products and contamination. (1999) (3)
Australia antigen and primary liver cancer (1970) (3)
Anti-interleukin-5 therapy and severe asthma. (2009) (3)
Eosinophilic myocarditis manifesting as myocardial infarction (1997) (3)
The functions of eosinophils. (1986) (3)
Epithelial damage is commonly seen in nasal polyps (1982) (3)
Coexistence of celiac disease and eosinophilic gastroenteropathy. (2001) (3)
Update on immunogenicity in severe asthma: Experience with mepolizumab. (2019) (3)
Local Immunity in Respiratory Tract (1979) (3)
S1075 Interim Analysis of the Utility of an Elemental Diet in Adult Eosinophilic Esophagitis (2010) (3)
Delayed Gastrointestinal Symptoms after Ingesting Shrimp in the Absence of IgE Sensitization (2012) (3)
Immune responses to the hemocyanin from Limulus polyphemus in allergic and normal individuals. (1972) (3)
Structure and activity of ragweed antigen E--III. The role of the thiol group in the conformation and allergenic activity of antigen E. (1980) (2)
The effect of immunotherapy on seasonal changes in IgE antibody to ragweed (1976) (2)
Heparanase is contained in human peripheral blood eosinophils and its activity is inhibited by eosinophil granule basic proteins (2003) (2)
Immunoglobulin E and atopic diseases. (1973) (2)
Cytotoxicity of Platelet Activating Factor (PAF) to the Human Nasal Mucosa (1988) (2)
Activate the Synthesis of Remodeling Factors Eosinophil-Derived Cationic Proteins (2006) (2)
Standardization of allergen extracts. (1981) (2)
IgE, allergy, and the gut (1980) (2)
379 Failure to detect neutrophil degranulation in patients with atopic dermatitis (AD): Implications for pathophysiology (1991) (2)
Increased microvascular permeability induced by eosinophil proteins. (1995) (2)
Urine eosinophil‐derived neurotoxin: A potential marker of activity in select eosinophilic disorders (2022) (2)
EOSINOPHILS AND MAST CELLS/BASOPHILS (1991) (2)
Isolation of a major peanut allergen (1980) (2)
133 Variability in the quantitation of IgE protein in cell culture supernatants (1985) (2)
Serum IgE Concentrations in Bullous Pemphigoid Correlate with Disease Activity (2007) (2)
Variations of the Radioallergosorbent Test for Measurement of IgE Antibody Levels, Allergens and Blocking Antibody Activity (1981) (2)
Genetic control of the immune response to trichinella spiralis in the mouse. A role for genes within the major histocompatibility complex. Abstr. (1979) (2)
Oral Administration of 99mTechnetium-Labeled Heparin in Eosinophilic Esophagitis. (2020) (2)
156 Injurious effect of the eosinophil peroxidase-hydrogen peroxide-halide system on nasal epithelium in vitro (1988) (2)
140 Glucocorticoids (GC) inhibit rIL-5-enhanced in vitro survival of eosinophils (1991) (2)
Dexpramipexole: a new antieosinophil drug? (2018) (2)
IgE and diseases of the skin (1973) (2)
Patchy Eosinophil Infiltration in an Eosinophilic Esophagectomy With Implications for Clinical Biopsy Ascertainment of EoE Patients (2011) (2)
[43] Double-antibody radioimmunoassay for IgE (1981) (2)
Treatment of ragweed hay fever with intranasal cromolyn solution (1976) (2)
EOSINOPHILS : GRANULE PROTEINS (1998) (2)
Treatment of the Hypereosinophilic Syndrome with Interferon- (1995) (2)
32. Evidence for increased risk of development of asthma in patients with nasal polyps (1978) (2)
Silent but widespread use of dietary supplements. (1999) (1)
Long-term Safety And Efficacy Of Mepolizumab For The Treatment Of Hypereosinophilic Syndrome (2012) (1)
268 Neutrophils and allergic inflammation (1988) (1)
Specificity of serum IgE antibody reactive with tobacco leaf antigens (1982) (1)
Ra3 skin test response and HLA-A2, antigen E, and IgE: evidence of interactions between antigen E and HLA. (1982) (1)
Eosinophils and Anti-Pathogen Host Defense (2012) (1)
Double-antibody radioimmunoassay for IgE. (1981) (1)
838 Human eosinophils cultured with human interleukin 5 are hypodense, activated and have a distinct morphology (1991) (1)
What targeting the eosinophil has taught us about their role in diseases (2010) (1)
Update on eosinophils. (1989) (1)
VENOM IMMUNOTHERAPY FOR HONEYBEE STING-SENSITIVE PERSONS (1977) (1)
Contents, Vol. 94, 1991 (1991) (1)
Contents, Vol. 94, 1991 (1991) (1)
Immunology Immunochemistry and the Biosynthesis of Antibodies Felix Haurowitz (1968) (1)
Evaluation of skin tests in patients with penicillin allergy (1979) (1)
Eosinophils and hypersensitivity reactions. (1979) (1)
Developing and mature human granulocytes express ELP 6 in the cytoplasm. (2013) (1)
Case 26-1996: hypersensitivity to carbamazepine. (1997) (1)
Plasma levels of eosinophil granule major basic protein in pregnant cynomolgus monkeys. (1992) (1)
Comparative evaluation of quantitative polymerase chain reaction methods (1994) (1)
Eosinophils and Atopic Dermatitis (2002) (1)
Biopsy-proven eosinophilic endomyocardial disease: Survival analysis of 25 patients (1996) (1)
Measurement of IgE Protein and IgE Antibodies: The State of the Art (1984) (1)
MEPOLIZUMAB FOR THE TREATMENT OF PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS: A PHASE III RANDOMISED, PLACEBO-CONTROLLED TRIAL (2017) (1)
Development and application of novel immunoassays for eosinophil granule major basic proteins to evaluate eosinophilia and myeloproliferative disorders. (2021) (1)
Detection of antibody activity. (1969) (1)
837 Measurement of IL-5 by the eosinophil survival assay (1991) (1)
700 Eosinophils express and produce IL-4, IL-8, and IL-10 — Evidence for stored and newly synthesized cytokine (1996) (1)
Eosinophil mediated vasculitis in connective tissue disease (1993) (1)
Su1121 Phenotypically Differentiated Biopsy Selection Improves EoE Detection (2012) (1)
ROLES OF EOSINOPHILS AND NEUTROPHILS IN FATAL ASTHMA (1998) (1)
Eosinophil Proteins: Human eosinophil granule major basic protein homolog: biochemical, genetic and immunochemical aspects☆ (2000) (1)
Cardiomyopathy, Heart Failure and Protein-losing Enteropathy (1973) (1)
Oesophageal secretions reveal local food‐specific antibody responses in eosinophilic oesophagitis (2022) (1)
The Eosinophil and Bronchial Asthma : Current Perspecitves (1991) (1)
765 Measurement of the eosinophil peroxidase by immunoassay (2000) (1)
162 Eosinophil degranulation and IgG subclasses (1988) (1)
Non-invasive ultrasound to identify eosinophil granule proteins in eosinophilic esophagitis. (2015) (1)
Tissue eosinophilia induced by recombinant human interleukin-5 in the hamster cheek pouch membrane (1995) (1)
Eosinophil peroxidase increases membrane permeability in mammalian urinary bladder epithelium. (1999) (1)
755 Contact dermatitis from budesonide nasal spray (1996) (1)
S1858 Eosinophil Degranulation Differentiates Eosinophilic Esophagitis (EoE), Possible EoE and GERD Patients (2009) (1)
The role of the thiol group and the disulfide bond in the conformation and the IgE and IgG binding activities of ragweed allergen Ra3. (1981) (1)
Iconographies supplémentaires de l'article : Treatment of asthma with nebulized lidocaine: A randomized, placebo-controlled study (2011) (0)
Mediators and Eosinophils: Eosinophils and Hypersensitivity Reactions (1979) (0)
Failure to detect Charcot Leyden crystal protein and eosinophil granule major basic protein in human mast cells (1985) (0)
273 Comparison of structure and chromosome location of the human eosinophil major basic protein genes (2000) (0)
New insights into the role of the eosinophil in allergic disease. (1985) (0)
Erratum: Localization of disulfide bridges and free sulfhydryl groups in human eosinophil granule major basic protein (FEBS Letters (1994) 341 (213- 217)) (1994) (0)
Su1827 Mbp-1 Specific Ultrasound Contrast Agents: A New Approach to Noninvasively Detect Eosinophilic Esophagitis Associated Inflammation (2013) (0)
75 Characterization of eosinophils in a continuous ambulatory peritoneal dialysis patient with eosinophilic peritonitis (1991) (0)
Immunochemical studies on some immune systems involving beta-(1,4) linked glucose. (1965) (0)
519 Recombinant antigen-specific IgG and IgA, but not IgE, induces degranulation and superoxide production by human eosinophils (2000) (0)
355 Effects of protein kinase inhibitors on eosinophil degranulation induced by secretory IgA (sIgA) conjugated sepharose beads (1996) (0)
Urine eosinophil‐derived neurotoxin declines following mepolizumab treatment in subjects with Eosinophilic Granulomatosis with Polyangiitis: 877 (2019) (0)
Eosinophil Active Cytokines in the Broncho Alveolar Lavage Fluids of Bronchial Asthma Patients (1994) (0)
SPLENOMEGALY IN IDIOPATHIC HYEREOSINOPHILIC SYNDROME. AUTHORS' REPLY (1996) (0)
Allergy to tobacco antigens (1979) (0)
Novel targeted therapies for eosinophilic disorders The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters (2013) (0)
412 The importance of nasal allergen specific IgA and eosinophils in seasonal allergic rhnitis (1991) (0)
825 Deposition of extracellular neutrophil elastase (ELAST) and eosinophil major basic protein (MBP) in the bronchial tree epithelium in fatal asthma (FA) (1991) (0)
Cartographie de l'activation des éosinophiles in vivo en cas d'œsophagite à éosinophiles (2011) (0)
353 Spontaneous survival of eosinophils and IL-5 levels in patients with idiopathic hypereosinophilic syndrome (HES) (1996) (0)
procyonis)Encephalitis Proteins in 2 Children With Raccoon Roundworm (Baylisascaris Eosinophil-Associated Inflammation and Elaboration of Eosinophil-Derived (2013) (0)
Effects of corticosteroid hormones on eosinophilotaxis (1975) (0)
immunologic stimuli Human eosinophils produce neurotrophins and secrete nerve growth factor on (2013) (0)
When Esophageal Rings are Present but Eosinophils are Sparse: Is Degranulation a Factor? (2008) (0)
Dexamethasone and lidocaine suppress eosinophilopoiesis from umbilical cord blood cells (2020) (0)
Eosinophils (1990) (0)
358 Cross-linking of CD9 induces degranulation, GM-CSF production and survival of human eosinophils (1996) (0)
162 a ,-Antitrypsin in serum and synovial fluid in rheumatoid arthritis (0)
Biodistribution of orally administered 99mTc-heparin to assess eosinophilic esophagitis associated inflammation (2019) (0)
Over-the-counter melatonin products and contamination [2] (multiple letters) (1999) (0)
The effect of immunotherapy on seasonal changes in IgE antibodies to ragweed antigens: A prospective study (1979) (0)
Production of an antiserum to guinea pig eosinophils (1975) (0)
Patent Number : 45 )-Date of Patect : ( 54 ) TREATMENT OF EOSINOPHIL ASSOCATED PATHOLOGIES BY ADMINISTRATION OF TOPICAL ANESTHETICS (0)
Alkali bees: response of adults to pathogenic fungi in brood cells. (1969) (0)
Impact of Baseline Blood Eosinophil Count on Flare Reduction in Mepolizumab-Treated Patients With Hypereosinophilic Syndrome (2021) (0)
Progress in Clinical Immunology (1973) (0)
Hypersensitivity to Drugs (1973) (0)
Contents, Vol. 114, Supplment 1, 1997 (1997) (0)
Cellular Immunology M. Burnet (1970) (0)
From Molecular Science to the Treatment of Allergy (1999) (0)
Cathepsin B is required for maturation of eosinophil major basic protein (2002) (0)
Eosinophils HumanIL-5-Mediated Survival and Activation of Lidocaine and its Analogues Inhibit (1998) (0)
Does Eosinophil Depletion in Gastroenteric Diseases Associated With the Hypereosinophilic Syndrome Teach Us Whether Normal Humans Need Eosinophils in 2022? (2022) (0)
Does IgE Bind to and Activate Eosinophils (1999) (0)
Alteration of human in vitro T cell proliferative response in atopy: Decreased autologous MLR in atopics and depression of proliferative response to specific allergen after immunotherapy (1981) (0)
2. EOSINOPHILS IN ALLERGIC DISEASES : EVIDENCE FOR EOSINOPHIL DEGRANULATION IN ALLERGIC DISEASES OF THE EYE, UPPER AIRWAY AND THE SKIN (1991) (0)
The Pathogenic Role of Eosinophils in Hypereosinophilic Syndrome (HES) (2017) (0)
Eosinophil Survival and Activation Sulfonylureas Inhibit Cytokine-Induced (1998) (0)
Comparison of Certain Properties of Naturally Occurring Low Molecular Weight γM and the γM Monomer Derived by Reduction and Alkylation of 19 S γM (1968) (0)
Identification of a major protein constituent from guinea pig eosinophil granules (1973) (0)
Characterization of eosinophil granule major basic protein activation of human basophil histamine release (1985) (0)
20 Human basophils contain the eosinophil granule major basic protein (1983) (0)
169. Measurement of the potency of allergy extracts by radioimmunoprecipitation (RIP) with radiolabeled crude pollen extracts (1978) (0)
Highlights of the 48th Annual Meeting of the American Academy of Allergy and Immunology (1993) (0)
Book Review The Immunological Basis of Asthma (Lung Biology in Health and Disease. Vol. 174.) Edited by Bart N. Lambrecht, Henk C. Hoogsteden, and Zuzana Diamant. 800 pp., illustrated. New York, Marcel Dekker, 2003. $195. 0-8247-0882-2 (2004) (0)
Localization of Eosinophils to Different Subspecies of Nerves in Inflammatory Bowel Disease (2004) (0)
821 The interaction of the eosinophil major basic protein (MBP) with synthetic lipid belayers (1991) (0)
Sa1836 A New Approach to Image and Enhance Diagnosis of EoE: Radiolabeled Contrast Agents (2012) (0)
Eosinophil-Active Cytokines in Human Disease: Development and Use of Monoclonal Antibodies to IL-3, IL-5, and GM-CSF (2019) (0)
Physicochemical and immunochemical properties of tobacco extracts (1979) (0)
Cough Hypersensitivity Induced by Eosinophil Granule‐Derived Major Basic Protein in Awake Mice (2019) (0)
121. Association of Ra5 sensitivity with HLA (1978) (0)
Allergic rhinitis and asthma induced by boxelder bug sensitization. (2019) (0)
Eotaxin-3 Immunofluorescence in Adults with Dysphagia: Is There More to Eosinophilic Esophagitis Than Meets the Microscopic Eye?: 105 (2007) (0)
395 Mast cells are not playing a role in eosinophil accumulation induced by allergen in vivo (1996) (0)
Eosinophil Granule Proteins: Structure and Function (2019) (0)
Rostrum Refining the definition of hypereosinophilic syndrome (2011) (0)
Use of local anesthetic for the manufacture of a medicament for the treatment of bronchial asthma (1994) (0)
431 The effects of eosinophil peroxidase and major basic protect on beta-adrenergic receptors (1991) (0)
Contents, Vol. 39, 1970 (1970) (0)
Significance of pregnancy-associated major basic protein (pMBP) in trophoblastic disease (1992) (0)
Acknowledgements (2004) (0)
826 Measurement of eosinophil, neutrophil, and mast cell proteins in sputum from patients with asthma and chronic obstructive pulmonary disease (1991) (0)
Molecular characterization of the murine eosinophil secondary granule proteins and their potential relevance to the evolution of effector function (1996) (0)
Eosinophil major basic protein increases membrane permeability in mammalian urinary bladder epithelium. (1998) (0)
135. RAST-standardized ragweed extract in a clinical allergy practice (1978) (0)
121. Relationship of allergic responses to Ra3 and HLA (1978) (0)
Dependent Pathway ζ C-Phosphoinositide 3-Kinase and Protein KinaseA Neutrophil Superoxide Production by a Class I Eosinophil Major Basic Protein Stimulates (2003) (0)
Are Eosinophils Needed for Normal Health? (2022) (0)
5. AIRWAY INFLAMMATION AND INFLAMMATORY CELLS (1991) (0)
Facial Edema and Eosinophilia (2020) (0)
62 好酸球筋痛症候群(EMS), Toxic oil syndrome(TOS), Hypereosinophilic syndrome(HES)におけるhypodense eosinophilおよびcytokineについての検討 (1993) (0)
Subspecialty Clinics: Nephrology Acute Interstitial Nephritis: Immunologie and Clinical Aspects (1988) (0)
Book Review Breathing Space: How Allergies Shape Our Lives and Landscapes By Gregg Mitman. 312 pp., illustrated. New Haven, CT, Yale University Press, 2007. $30. 978-0-300-11035-7 (2007) (0)
Cell screening assay for identifying inhibitors of eosinophil proliferation (2011) (0)
47 Calcium dependent ionophore A23187 induced eosinophil degranulation and cytolysis (1985) (0)
Active on Eosinophils : Potential Roles in Al lergic (2003) (0)
from Patients with Allergy? Does IgE Bind to and Activate Eosinophils (1999) (0)
CONSENSUS DOCUMENT ICON : Eosinophil Disorders (0)
47 Relationship of the immune response to purified ragweed antigens and the HLA-Dr system (1983) (0)
Sa1185 Biodistribution of Orally Administered 99mtc-Heparin: A Radiolabeled Contrast Agent for Eosinophilic Esophagitis Associated Inflammation (2013) (0)
Su1850 Eosinophil Degranulation Patterns in Eosinophilic Esophagitis (2013) (0)
Reactivity of Polymer (19S) and Monomer (7S) Forms of γM with Anti-γM Serum (1969) (0)
Lidocaine may inhibit interleukin-5-induced signal transduction by blocking protein kinase C activity (2002) (0)
Localization of eosinophil granule major basic protein in human cells (1982) (0)
Novel Glucocorticomimetic Agents Active on Eosinophils: Potential Uses in the Therapy of Asthma (1998) (0)
mmunological and biochemical studies beekeepers and their famil (1978) (0)
IL1 Markers of Eosinophil Participation in Disease (2009) (0)
II. Allergenic crossreactivity of the subunits (1979) (0)
superoxide anion production by eosinophil granule major basic Analysis of signaling events associated with activation of neutrophil (2011) (0)
Eosinophil proteins and immunoglobulin E levels in pruritic urticarial papules and plaques of pregnancy syndrome (1983) (0)
Surface expression of eosinophil major basic protein (MBP) and eosinophil peroxidase (EPO), without apparent extracellular release, by activated human eosinophils (2003) (0)
823 Localization of eosinophil granule major basic protein in patients with eosinophilic gastroenteritis (EG) and celiac sprue (CS) (1991) (0)
episodic angioedema and eosinophilia Elevated serum levels of interleukin-5 in patients with the syndrome of (2011) (0)
Eosinophils Stimulated with IL-5 or IgG Critically Involved in Effector Functions of Endogenous Platelet-Activating Factor Is and Hirohito Kita (1999) (0)
An Eosinophil Peroxidase Activity Assay Accurately Predicts Eosinophilic Chronic Rhinosinusitis (2023) (0)
Baseline Demographics and Disease Characteristics of Patients with Hypereosinophilic Syndrome in a Placebo-Controlled Trial Evaluating the Steroid-Sparing Effects of the Anti-IL-5 Monoclonal Antibody, Mepolizumab. (2006) (0)
Wanted: Eosinophils, Dead or Alive? Eosinophil Cell Death Subroutines and Implications for Eosinophil-Targeted Therapy (2014) (0)
Editorial: Update on eosinophils (1989) (0)
821 Effects of Mepolizumab, an Anti-Interleukin-5 Monoclonal Antibody, on Blood Eosinophil Counts in Patients With Hypereosinophilic Syndrome (2007) (0)
Eosinophils in Bronchial Asthma (1987) (0)
Pharmacological control ofhumanbasophil histamine release stimulated byeosinophil granule majorbasic protein (1989) (0)
Faculty Opinions recommendation of Interleukin-5 induces CD34(+) eosinophil progenitor mobilization and eosinophil CCR3 expression in asthma. (2002) (0)
Eosinophil-Activating Factor Biological Activities of Ecalectin: A Novel (2002) (0)
Eosinophil-mediated bile duct stricture. A case studied by immunohistochemistry. (1992) (0)
Changes in the antigen E content of short ragweed during maturation (1973) (0)
InflammationOvalbumin-Challenge Model of Pulmonary Proteins Do Not Occur in a Mouse Peroxidase-Mediated Oxidation of Airway Extensive Eosinophil Degranulation and (2001) (0)
Refining the definition of hypereosinophilic syndrome The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters (2012) (0)
Treatment of eosinophilic esophagitis with biological agents (2012) (0)
Identification of a complex formed by eosinophil major basic protein and a putative receptor on neutrophils (1996) (0)
Characteristics of eosinophil colony-forming cells in bone marrow and peripheral blood (1982) (0)
Su1109 The Eosinophil Peroxidase (EPO) Brush Assay: Minimally Invasive Method to Measure Inflammation in Eosinophilic Esophagitis (2015) (0)
[Sputum eosinophilic proteins in asthma. Role of bronchopulmonary superinfection]. (1983) (0)
EMBP Heparin complex (2005) (0)
Allergic Inflammation Eosinophil Infiltration in a Mouse Model of IL-5 Production by NK Cells Contributes to (1998) (0)
S1877 Association of Food Allergies with Eosinophilic Esophagitis (2009) (0)
Iconography : Familial eosinophilic cellulitis, dysmorphic habitus, and mental retardation (2011) (0)
Eosinophils display and activated phenotype in clinically active inflammatory bowel disease (2004) (0)
Acknowledgements (1997) (0)
Biographical Sketch of Dr. Alec H. Sehon (1991) (0)
Biographical Sketch of Dr. Alec H. Sehon (1991) (0)
IRp60 is expressed and functional on human cord blood derived mast cells (2004) (0)
Books received for review (1947) (0)
clustering with downstream MAPK cell signaling (0)
Cytotoxicity of Human Eosinophil Granule Major Basic Protein (MBP) to the Human Nasal Mucosa (1988) (0)
β2 Integrin-dependent tyrosine phosphorylation of proline-rich tyrosine kinase 2 in platelet-activating factor-activated eosinophils (2000) (0)
Contents, Vol. 66, Supplement 1, 1981 (1981) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Gerald J. Gleich?

Gerald J. Gleich is affiliated with the following schools:

Gerald J. Gleich's Academic­Influence.com Rankings

Gerald J. Gleich's Degrees

Why Is Gerald J. Gleich Influential?

Gerald J. Gleich's Published Works

Published Works

What Schools Are Affiliated With Gerald J. Gleich?

Gerald J. Gleich's AcademicInfluence.com Rankings